GoodRx Holdings, Inc. (GDRX) research
GoodRx Holdings, Inc.- Sector
- Health Care
- Last price
- $3.44
- As of
GoodRx Holdings, Inc. (GDRX): 6 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-08-05.
As of . Source: SEC EDGAR filings for GDRX. Method and limitations.
Share the GDRX intelligence card
See GDRX live in the terminal
Track GDRX's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.
Open the live GDRX terminal, freeActive signals for GDRX
- highCONSENSUS_SELL
3 tracked funds reduced GDRX this 2026Q2, institutional consensus
- highCONSENSUS_BUY
3 tracked funds increased GDRX this 2026Q2, institutional consensus
- highCONSENSUS_BUY
3 tracked funds increased GDRX this 2026Q2, institutional consensus
- highINSTITUTIONAL_EXIT
Point72 Asset Management, L.P. cut 96% of GDRX (2026Q2)
- highINSTITUTIONAL_SURGE
MILLENNIUM MANAGEMENT LLC added +1303% to GDRX (2026Q2)
FREE, NO ACCOUNT
Every signal on GDRX, as it fires
You are seeing 5 of 31 signals recorded on GDRX since 2026-05-24.
The five above landed across 2 days. The other 26 were recorded on 3 other days. 23 of the 31 are institutional flow rows, which arrive in batches on filing days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in GDRX (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLCCUSIP 38246G108 · 2026Q2 | $9.3M | 0.01% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 38246G108 · 2026Q2 | $2.1M | 0.00% | , |
| D. E. Shaw & Co., Inc.CUSIP 38246G108 · 2026Q2 | $1.4M | 0.00% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 38246G108 · 2026Q2 | $1M | 0.00% | , |
| CITADEL ADVISORS LLCCUSIP 38246G108 · 2026Q2 | $300K | 0.00% | , |
| Point72 Asset Management, L.P.CUSIP 38246G108 · 2026Q2 | $56K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, GDRX
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
GDRX against its peers
GDRX's operating margin of 11.0% ranks in the 87th percentile of 25 Health Care sub-industry peers, fiscal periods ending between 2025-10-03 and 2026-01-02.
| Metric | GDRX | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 797M USD | 781M USD | 52 | 25 |
| Gross margin | n/a | 59.1% | n/a | 16 |
| Operating margin | 11.0% | 1.4% | 87 | 25 |
| Net margin | 3.8% | -0.4% | 75 | 25 |
| Return on equity | 4.9% | -0.9% | 63 | 25 |
| P / E | 38.2x | 47.2x | 25 | 9 |
Peers (25): TDOC, TNDM, USPH, IRMD, PRCT, CSTL, CERT, OMDA, STAA, AMN, CNMD, PNTG, OMCL, BVS, ATEC, TALK, HSTM, VREX, AHCO, LMAT, NVCR, EHAB, XRAY, SEM, PGNY. Fiscal periods ending between 2025-10-03 and 2026-01-02. Every figure is one full fiscal year read from one annual filing (GDRX: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more GDRX signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to GDRXand get the insider, 13F, options, and confluence read in one view.